Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Sep;1(3):173-80.
doi: 10.3978/j.issn.2223-4683.2012.07.01.

Regenerative technology for future therapy of erectile dysfunction

Ji-Kan Ryu  1 , Jun-Kyu Suh  1
Affiliations
Review

Regenerative technology for future therapy of erectile dysfunction

Ji-Kan Ryu et al. Transl Androl Urol. 2012 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Schematic diagram summarizing the use of regenerative technology (pharmacotherapy, protein therapy, gene therapy, and cell therapy) to treat erectile dysfunction. VEGF-A, vascular endothelial growth factor-A; Ang1, angiopoietin 1; bFGF, basic fibroblast growth factor; GDF-5, growth differentiation factor-5; BDNF, brain-derived neurotrophic factor; GDNF, glial cell line-derived neurotrophic factor; ADSCs, adipose tissue-derived stem cells; AD-SVF, adipose tissue-derived stromal vascular fraction; BMSCs, bone marrow-derived stem cells; eNOS, endothelial nitric oxide synthase; EPCs, endothelial progenitor cells; SkMDCs, skeletal muscle-derived cells; ESCs, embryonic stem cells.
Figure 2
Figure 2
Schematic diagram depicting the concept of combination therapy for erectile dysfunction. The numbering or order in the pathophysiology and treatment strategy section was determined according to the priority of importance.
Figure 3
Figure 3
Schematic diagram illustrating the concept of targeted therapy based on molecular pathophysiology to treat erectile dysfunction.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Dorsey P, Keel C, Klavens M, et al. Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction. Expert Opin Pharmacother 2010;11:1109-22. - PubMed
    1. Lysiak JJ, Kavoussi PK, Ellati RT, et al. Angiogenesis therapy for the treatment of erectile dysfunction. J Sex Med 2010;7:2554-63. - PubMed
    1. Lee RJ, Springer ML, Blanco-Bose WE, et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000;102:898-901. - PubMed
    1. Augustin HG, Koh GY, Thurston G, et al. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009;10:165-77. - PubMed
    1. Jin HR, Kim WJ, Song JS, et al. Intracavernous delivery of a designed angiopoietin-1 variant rescues erectile function by enhancing endothelial regeneration in the streptozotocin-induced diabetic mouse. Diabetes 2011;60:969-80. - PMC - PubMed